Literature DB >> 26231458

Estimating the global prevalence of hepatitis B.

Jennifer H MacLachlan1, Stephen Locarnini2, Benjamin C Cowie2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26231458     DOI： 10.1016/S0140-6736(15)61116-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.

Authors:  Eva C Schwaneck; Manuel Krone; Sonja Kreissl-Kemmer; Benedikt Weißbrich; Johannes Weiss; Hans-Peter Tony; Ottar Gadeholt; Marc Schmalzing; Andreas Geier
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

2.  Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.

Authors:  Philip Rosenthal; Simon C Ling; Steven H Belle; Karen F Murray; Norberto Rodriguez-Baez; Sarah J Schwarzenberg; Jeffrey Teckman; Hsing-Hua S Lin; Kathleen B Schwarz
Journal:  Hepatology       Date:  2019-02-20       Impact factor: 17.425

3.  Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community.

Authors:  Jing-Chen Ma; Zhi-Wei Wu; Hai-Song Zhou; Zhao Gao; Zhi-Yong Hao; Fei Jin; Yan-Hong Zhang; Min-Jie Li; Feng Wang; Qi Li; Sheng-Li Bi; Yu-Liang Zhao
Journal:  Hum Vaccin Immunother       Date:  2019-08-29       Impact factor: 3.452

4.  Determinants of hepatitis B vaccination status in health care workers of two secondary care hospitals of Sindh, Pakistan: a cross-sectional study.

Authors:  Salman Muhammad Soomar; Amna Rehana Siddiqui; Syed Iqbal Azam; Mairaj Shah
Journal:  Hum Vaccin Immunother       Date:  2021-11-10       Impact factor: 3.452

5.  Fluorescence based Aptasensors for the determination of hepatitis B virus e antigen.

Authors:  Rongrong Huang; Zhijiang Xi; Yan Deng; Nongyue He
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

6.  Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA.

Authors:  Thomas Michler; Stefanie Große; Stefan Mockenhaupt; Natalie Röder; Ferdinand Stückler; Bettina Knapp; Chunkyu Ko; Mathias Heikenwalder; Ulrike Protzer; Dirk Grimm
Journal:  EMBO Mol Med       Date:  2016-09-01       Impact factor: 12.137

7.  Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.

Authors:  Jonathan Liu; Pedro Goicochea; Timothy Block; Carol L Brosgart; Eric F Donaldson; Oliver Lenz; Seng Gee Lim; Ed G Marins; Poonam Mishra; Marion G Peters; Veronica Miller
Journal:  J Virus Erad       Date:  2017-01-01

8.  Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis.

Authors:  Sajid Mahmood; Kifayat Ullah Shah; Tahir Mehmood Khan
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

9.  Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.

Authors:  Zeyu Sun; Xiaoli Liu; Daxian Wu; Hainv Gao; Jing Jiang; Ying Yang; Jie Wu; Qikang Gao; Jie Wang; Zhengyi Jiang; Youping Xu; Xiao Xu; Lanjuan Li
Journal:  Theranostics       Date:  2019-01-30       Impact factor: 11.556

10.  Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada.

Authors:  Norberto Rodriguez-Baez; Karen F Murray; David E Kleiner; Simon C Ling; Philip Rosenthal; Kristen Carlin; Kara Cooper; Kathleen B Schwarz; Sarah J Schwarzenberg; Jeffrey H Teckman; Marc G Ghany; Ahmad Samer Alawad
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-07       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.